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Loss-of-functionChordin is the prototype of a group of cysteine-rich domain-containing proteins that bind and modulate
signaling of various TGFβ-like ligands. Chordin-like 1 and 2 (CHL1 and 2) are two members of this group that
have been described in human, mouse, and chick. However, in vivo roles for CHL1 and 2 in early development
are unknown due to lack of loss-of-function analysis. Here we identify and characterize zebraﬁsh, Danio rerio,
CHL (Chl). The chl gene is on a region of chromosome 21 syntenic with the area of murine chromosome 7
bearing the CHL2 gene. Inability to identify a separate zebraﬁsh gene corresponding to the mammalian CHL1
gene suggests that Chl may serve roles in zebraﬁsh distributed between CHL1 and CHL2 in other species. Chl
is a maternal factor that is also zygotically expressed later in development and has spatiotemporal
expression patterns that differ from but overlap those of zebraﬁsh chordin (Chd), suggesting differences but
also possible overlap in developmental roles of the two proteins. Chl, like Chd, dorsalizes embryos upon
overexpression and is cleaved by BMP1, which antagonizes this activity. Loss-of-function experiments
demonstrate that Chl serves as a BMP antagonist with functions that overlap and are redundant with those of
Chd in forming the dorsoventral axis.y and Laboratory Medicine,
, WI 53706, USA. Fax: +1 608
).
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Modulation of signaling by ligands of the TGFβ superfamily, crucial
to morphological events, is accomplished in part by various
extracellular antagonists, which include chordin/sog, noggin, follis-
tatin, and the DAN/cerberus family (Massague and Chen, 2000).
Chordin (CHD), which is perhaps the best studied of these, acts by
non-covalent binding of BMPs 2 and 4 in a latent complex, thus
inhibiting BMP interaction with cell surface receptors (Piccolo et al.,
1996). CHD has also been shown to bind BMP4-BMP7 heterodimers in
the Xenopus system (Piccolo et al., 1996, 1997) and probably acts in
zebraﬁsh via binding Bmp2–Bmp7 heterodimers (Little and Mullins,
2009). CHD binds BMPs via four cysteine-rich domains (CRs 1–4)
(Larrain et al., 2000) and cleavage of CHD downstream of CRs 1 and 3
by BMP1/Tolloid-like proteinases liberates BMPs from the latent
complex (Piccolo et al., 1997; Scott et al., 1999). This conservedmechanism of binding and release underlies dorsoventral patterning
in organisms ranging from Drosophila to mammals (Blader et al.,
1997; Marques et al., 1997; Pappano et al., 2003; Piccolo et al., 1997;
Scott et al., 1999). CHD is the prototype of a small group of
extracellular proteins containing CRs that possess conserved CXXCXC
and CCXXC motifs (Garcia Abreu et al., 2002). Most of the sequence
homology existing between members of this protein group, a number
of which have been shown to bind BMPs, is conﬁned to the CRs
(Garcia Abreu et al., 2002).
CHD-like 1 and 2 (CHL1 and CHL2), members of this group of
proteins, each contain three CRs. Both long and short forms of CHL1
have been reported, differing in the lengths of sequences C-terminal
to CR3 (Nakayama et al., 2001; Sakuta et al., 2001). The short and long
forms have been designated by some as neuralin-1 (Cofﬁnier et al.,
2001) and ventroptin (Sakuta et al., 2001), respectively. Both forms
bind BMP4 with high afﬁnity, with somewhat lesser afﬁnity shown by
the short form for BMPs 5 and 6, and TGFβs 1 and 2, and no binding
shown by the short form for activin (Nakayama et al., 2001; Sakuta
et al., 2001). Lesser afﬁnity is shown by the long form for BMP4/7
heterodimers, and no binding by the long form was detected for
BMP7, TGFβ1, or activin A (Nakayama et al., 2001; Sakuta et al., 2001).
Consistent with the binding data, both short and long forms induce
secondary axes when overexpressed in Xenopus embryos (Nakayama
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mouse embryos (Nakayama et al., 2001) but was found in neural plate
at late gastrulation (Cofﬁnier et al., 2001), in somites at 9.5-dpc, and
thereafter in presumptive and hypertrophic cartilage, neural crest
cells and their derivatives, mesenchymal/stromal cells throughout
the body, developing CNS, and in several adult organs (Cofﬁnier et al.,
2001; Kosinski et al., 2007; Nakayama et al., 2001). In chick, the long
form was found in ventral retina, where it may help control
topographic retinotectal projections by establishing dorsoventral
and anteroposterior gradients of inhibition to signaling by BMP4
and related ligands (Sakuta et al., 2001).
CHL2 reportedly binds BMPs 2 and 4–7 and GDF5, but not activin A
or TGFβs 1–3; blocks induction of osteogenic differentiation by BMPs
2, 4, 6, and 7; and induces secondary dorsal axes upon overexpression
in Xenopus embryos (Nakayama et al., 2004). It has conversely been
reported to bind activin A, but not BMP 2, 4, or 6 (Oren et al., 2004),
although the latter study employed a slightly longer variant of CHL2,
whichmay explain differences in reported CHL2 afﬁnities. The slightly
longer CHL2 variant has also been designated breast tumor novel
factor 1 (BNF-1) and is overexpressed in tumors of human breast,
lung, and colon (Wu and Moses, 2003). CHL2 is also expressed in
developing articular cartilage, suggesting a role in joint speciﬁcation;
it has been shown able to inhibit chondrocyte hypertrophic
differentiation and formation of cartilaginous mineralized extracellu-
lar matrix, and it may play a role in regenerating osteoarthritic
cartilage (Nakayama et al., 2004). CHL2 RNA has also been found in
uterus and colon, connective tissues associated with reproductive
organs, osteoblasts, epithelial cells of reproductive organs and
bladder, and in other mouse and human soft tissues (Nakayama
et al., 2004; Oren et al., 2004; Wu and Moses, 2003).
In the above studies, CHL1 and 2 spatial and temporal expression
proﬁles clearly differed from those of CHD, suggesting functional
differences. Precise in vivo functions of the CHL proteins remain
largely unknown, due in part to the lack of loss-of-function data for
either protein. Here we identify zebraﬁsh CHL (Chl), which has
sequences and a protein domain structure similar to those of CHL1
and CHL2. Overexpression analysis shows that Chl, like zebraﬁsh CHD
(Chd), is capable of dorsalizing zebraﬁsh embryos, although Chl-
induced dorsalization is milder than that caused by Chd. In addition, it
is shown that Chl and CHL1, like Chd, can be cleaved by BMP1, the
expression of which leads to rescue of embryos dorsalized by Chl
overexpression. Temporal and spatial expression patterns of Chl are
shown to differ from but to overlap those of Chd, consistent with
differences and with the possibility of similarities in their develop-
mental roles. Chl is shown to be both a maternal factor and zygotically
expressed. Loss-of-function experiments demonstrate Chl function,
including that of zygotically produced Chl, to overlap that of Chd in
formation of the dorsoventral axis.
Materials and methods
Identiﬁcation of Chl sequences
Mouse CHL2 amino acid sequences were used in a protein BLAST
search of the Danio rerio genome database on the NCBI assembled
genomes site, resulting in identiﬁcation of a zebraﬁsh “chordin-like 2”
protein (GenBank accession no. XP_691539.2) predicted from
automated computational analysis from sequences found on chro-
mosome 21 at location 19,863,200–19,876,300. A TBlastN protein vs.
translated DNA search of the zebraﬁsh Zv8 whole genome assembly
on the Sanger Institute site using mammalian CHL1 and CHL2 protein
query sequences identiﬁed the same gene on chromosome 21 and no
additional chordin-like genes. Although an Ensembl search of the Zv8
database with the term “chordin-like” gave two theoretical proteins,
“chordin-like” and “chordin-like protein 2”, both of these are based on
alternative predictions of intron/exon junctions of the same chl geneon chromosome 21, and no chordin-like proteins from additional
genes were identiﬁed. Primers 5′-GAGAAGACGTACAGGCCAGGAGAT-
3′ (forward) and 5′-GGGATGTTGGCACGGATACTGGTT-3′ (reverse),
corresponding to predicted sequences, were used to PCR amplify a
750-bp fragment using cDNA from total RNA of 48-hpf zebraﬁsh as
template. 5′ and 3′ RACE were then employed to obtain additional 5′
and 3′ cDNA sequences, using as template an adult zebraﬁsh cDNA
library (Open Biosystems). For 5′ RACE, a primary reaction was with
vector primer (VP) 5′-GCGGATAACAATTTCACACAGGAAACA-3′ and
gene-speciﬁc primer (GSP) 5′-GGGATGTTGGCACGGATACTGGTT-3′,
and 5 μl of the product from this PCR was used as template for the
second nested reaction with VP 5′-GCTATGACCATTAGGCCTATT-
TAGGT-3′ and GSP 5′-ACTGACGGGTTGGGAATAGCTCAT-3′. For 3′
RACE, a primary reaction was with GSP 5′-GAGAAGACGTACAGGC-
CAGGAGAT-3′ and VP 5′-CAGTTTTCCCAGTCACGACGTTGT-3′, and 5 μl
of this product was used as template for the second nested reaction
with GSP 5′-GATAGTTGGCATCCCTATTTGGAAC-3′ and VP 5′-AAAC-
GACGGCCAGTGCCTAGCTTA-3′. The 2123-bp cDNA sequences
obtained in the above manner, including full-length coding
sequences, 61 bp of 5′ UTR and 697 bp of 3′ UTR, have been deposited
with the EMBL/GenBank Data libraries under accession no. EU030433.
RT-PCR
Embryos were collected from various stages (8 cell to 48 hpf)
followed by total RNA extraction using Trizol Reagent (Invitrogen).
SuperScriptIII (Invitrogen) reverse transcriptase was used to synthesize
cDNA from1 μg of total RNAper stage. PCRwas performedwith primers
5′CGCATCTGTGCACGGATCGAGACTC 3′ (forward) and 5′CAGCCAA-
GAGTCTGTCACACCCGTC 3′ (reverse) for Chd; 5′GGTGATGACCTGGGAG-
CAAATGATG 3′ (forward) and 5′GACAAGTGTCCTGGTGTGGGAGATC 3′
(reverse) for Tcf3; and 5′ GAGAAGACGTACAGGCCAGGAGAT 3′ (for-
ward) and 5′ GGGATGTTGGCACGGATACTGGTT 3′ (reverse) for Chl.
Resulting amplicon sizes were 451-bp (Tcf3), 493-bp (Chd), and 806-bp
(Chl). For the experiment in which speciﬁcity of the splice site MO SP-
MO was tested, RNA was extracted from embryos treated with 0.5 mM
SP-MO, and PCRwas performedwith primers 5′GAGAAGACGTACAGGC-
CAGGAGAT3′ (forward) and 5′CTTTGCACACTAGGCAGCAAGTATC3′
(reverse).
Morpholino (MO) injections
Chl-MOs were obtained from Gene Tools. An MO targeted against
the Chl translation start site (TrSt-MO) was 5′ CAGGTCATTCTTTTCTT-
CATATTCC 3′, whereas an MO targeted against chl 5′-UTR sequences
(5′1-MO) was 5′AAAAACTGGAGACGCAGGATTTGTC 3′. An RNA splice
disrupting MO (SP-MO) 5′ GCTCATCTGATGATAGGAATATAC 3′ targets
the exon 4 acceptor splice site. A standard control MO (StCon-MO) 5′
CCTCTTACCTCAGTTACAATTTATA 3′ has no target and no biological
activity in zebraﬁsh (Gene Tools). MOs were resuspended in sterile
double distilled water at a concentration of 2 mM, diluted to the
desired concentrations prior to injection, and injected with 0.1%
phenol red tracer into one-cell stage embryos. Injection volume was
1 nl.
Chl–Chd synergy and rescue
A previously described, Chd-MO (Nasevicius and Ekker, 2000),
diluted to a concentration (0.026 mM) that exhibited amild ventralized
phenotypewhen injected alone,was co-injectedwith 0.1 mMof the Chl
5′1-MO or with a subthreshold concentration of SP-MO (0.5 mM) into
one- to two-cell stage embryos. Embryos were photographed and
quantiﬁed at 24 hpf. Rescue experiments of the additive effects of Chd-
MO combined with Chl 5′1 MO were performed using mouse CHL2,
mouse CHL1-Fc, and Chl RNA. This was executed by co-injecting
0.026 mM of the Chd-MO combined with 0.1 mM of the 5′1-MO and
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Chl RNA constructs, respectively.
RNA injections
Full-length Chl sequences or full-length mouse CHL2 sequences,
both with C-terminal FLAG epitopes and downstream of BM40 signal
peptide sequences, were excised from protein expression vectors (see
below) and then inserted between the EcoRI and XhoI sites of pCS2+,
withpartialﬁlling of the EcoRI sitewith dATPandpartialﬁlling of anAﬂII
site at the 5′ end of Chl or mouse CHL2 sequences with dTTP to create
compatible ends. The zebraﬁsh BMP1 (Bmp1a) construct for in vitro
expression of RNAhas been described previously (Jasuja et al., 2006). To
obtain full-length mouse CHL1 sequences with a C-terminal Fc domain
(CHL1-Fc), a construct in which CHL1 CR3 domain sequences were
cloned between theNheI andNotI sites of pcDNA4was cutwithNotI and
EcoO109I, followed by insertion of a linker assembled using oligonu-
cleotides 5′GCCCTAGGTCCCGTACGC3′ and 5′GGCCGCGTACGGGACC-
TAG3′. The resulting construct was cut with PpuMI and NotI, and
sequences encoding the murine Fc epitope, obtained from a previously
described GDF11-Fc plasmid (Ge et al., 2005) by excision with PpuMI
and NotI were inserted. The resulting construct was then cut with NheI
and Bsu15, and an NheI–Bsu15 restriction fragment encoding the
remainder of CHL1 sequences was inserted. CHL1-Fc sequences were
then cut from the resulting construct with NheI and XhoI and inserted
between the NheI and XhoI sites in a pCS2+ vector containing BM40
signal peptide sequences (Scott et al., 2001). Full-length Chd sequences,
missing only signal peptide sequences, were PCR ampliﬁed in two
pieces, using primer sets 5′GCTAGCATCGAGACTCAAGACACCCGCGCT-3′
and 5′TGTGTGTGTCTGGCCTCCACGCGT-3′ for the 5′end and 5′
ACGCGTGGAGGCCAGACACACACA-3′ and 5′CCACTCTAGAGAGTGT-
CAGTGTCTCCA-3′ for the 3′end. Both PCR products were cloned into
pGEM-T (Promega). The 3′end clonewas cutwith BstXI, treatedwith T4
DNA polymerase to remove anMluI site in the vector, and then cut with
MluI and NotI. The 5′ end clone was cut with Bsp120I andMluI, and the
insert band was gel puriﬁed and then ligated into the 3′end clone. The
resulting construct was cut withNheI and XbaI to release the full-length
Chd insert, which was then inserted between NheI and XbaI sites in a
version of the CS2+ vector containing the BM40 signal peptide.
BssHII was used to linearize the Chl, mouse CHL1-Fc, mouse CHL2,
and Bmp1a plasmids, NotI was used to linearize the Chd plasmid, and
cappedmRNAwas transcribed using themMessagemMachine SP6 kit
(Ambion). Following transcription, capped mRNAs were injected into
one- to two-cell stage embryos with 0.1% phenol red tracer.
Whole-mount in situ hybridization
In situ hybridizations were performed as described previously
(Pelegri and Maischein, 1998). The probe used for chd has been
previously described (Schulte-Merker et al., 1994). Images were
captured using a dissectingmicroscope (Leica, FLIII) and a color camera
(Diagnostic Instruments Spot Insight). Chl probes, corresponding to
sequences encoded by exons 1–5, were synthesized from a cDNA insert
ampliﬁed with primers 5′-CAATGCGGTGCTTTGTTCAGGGTG-3′ (for-
ward) and 5′-CTTTGCACACTAGGCAGCAAGTATC-3′ (reverse). The
resulting insert was ligated into the pGEM-T vector (Promega), followed
by linearization of the vector with NcoI or NotI and subsequent
transcription with SP6 or T7 polymerases for anti-sense and sense
RNA probes, respectively. Transcription employed the MAXIscript kit
(Ambion) and digoxigenin-labeled nucleotides (Roche).
Protein biochemistry
To produce recombinant Chl with a C-terminal FLAG tag, primers
GCTATCTAGAAACTGAGGCATTACGACCTGGA (forward) and
GATCGCGGCCGCTACTTGTCGTCATCGTCCTTGTAGTCAGATGTGCAAA-GACTGTCCAGCTGT (reverse) were used to amplify a full-length Chl
1339-bp PCR product, minus native signal peptide sequences, that
was then cut with XbaI and NotI and ligated between NheI and NotI
sites of a modiﬁed pcDNA4/TO/myc-His vector (Steiglitz et al., 2004),
such that CHL sequences were in frame and downstream of the signal
peptide of the extracellular matrix protein BM40/SPARC for optimi-
zation of secretion. To produce recombinant Bmp1a with a C-terminal
FLAG tag, primers CCAGACCTTCGAAATCGAGGAGGA (forward) and
GATGACCGGTCACTTGTCGTCATCGTCCTTGTAGTCCTTCTTACGG-
GAGTGGAGTGTGT (reverse) were used to PCR amplify a 280-bp
fragment using a previously described vector for expression of His-
tagged Bmp1a (Jasuja et al., 2006) as template. The 280-bp fragment
was then cut with BstBI and AgeI and was ligated into the original
Bmp1a-His construct, which had also been cut with BstBI and AgeI to
remove the corresponding fragment. To produce murine CHL2
(Nakayama et al., 2004) and the shorter neuralin form of murine
CHL1 (Cofﬁnier et al., 2001; Nakayama et al., 2001) with C-terminal
FLAG tags, primer sets 5′ AGTCAGCTAGCTGAACAAGTAAAACACTCA-
GACACA 3′ (forward CHL1), 5′ GCATGCGGCCGCTACTTGTCGT-
CATCGTCCTTGTAGTCACCAAAGGCAGGGCCTCCAGCCAA 3′ (reverse
CHL1) and 5′ AGTCAGCTAGCTCAAGCACTATCCCGCTCGGGCAAA 3′
(forward CHL2), 5′ GCATGCGGCCGCTACTTGTCGTCATCCGTCCTTG-
TAGTCTAATGTCTTGGTCACTTTGTCTGG 3′ (reverse CHL2) were used
to amplify full-length CHL1 and CHL2 sequences, minus native signal
peptide sequences, from mouse Marathon Ready cDNA (Clontech).
These were inserted downstream of the BM40 signal peptide,
between NheI and NotI sites of the modiﬁed pcDNA4/TO/myc-
His vector (Steiglitz et al., 2004). Constructs were transfected into
293 T-Rex cells using LipofectAmine (Invitrogen) followed by selec-
tion with blasticidin and zeocin. Cells were treated with tetracycline,
placed in serum-free media, and conditionedmedia were harvested at
24 and 48 h. FLAG-tagged proteins were puriﬁed from conditioned
media via a FLAG afﬁnity matrix column (Sigma) and concentrations
of puriﬁed proteins were calculated by comparing intensities of
Coomassie-stained bands from serial dilutions of each sample to those
of a serially diluted BSA standard of known concentration. In vitro
cleavage of Chl with Bmp1a was performed by incubating 200 ng Chl
alone or in the presence of Bmp1a. For in vitro cleavage of CHL1 and
CHL2, FLAG-tagged human BMP1, TLD, TLL1, and TLL2 were prepared
and puriﬁed as previously described (Scott et al., 1999). One hundred
ﬁfty nanograms of CHL1 or CHL2 was incubated overnight at 37 °C
alone or in combination with each mammalian proteinase. All in vitro
cleavage assays were at a 2:1 substrate to enzymemolar ratio at 37 °C
overnight in 50 mMCaCl2, 50 mM Tris–HCl, pH 7.5, and 150 mMNaCl.
Reactions were stopped by adding 10× SDS sample buffer and 5% β-
mercaptoethanol and boiling it for 5 min. Chl, Bmp1a samples were
run on a 4–15% acrylamide SDS–PAGE gradient gel, while mammalian
cleavage assay samples were run on a 12% SDS–PAGE gel. Electro-
phoresis was followed by transfer to PVDF membranes (Millipore)
and immunoblotting with anti-FLAG antibody diluted 1:5000 for all
proteins except for CHL1, which was detected with antibody to full-
length CHL1 (R&D Systems) diluted 1:1000.
For amino acid sequence analysis, cleaved CHL1 was electrotrans-
ferred to Sequi-Blot membrane (Bio-Rad), and NH2 sequences were
determined by automated Edman degradation at the Harvard
University Microchemistry Facility using a PerkinElmer Life
Sciences/Applied Biosystems Division Procise494 HT Protein Se-
quencing System.
Chl–GFP fusion construct
Sequences encoding green ﬂuorescent protein (GFP) were fused to
the C-terminus of Chl. This was done by using primers 5′-TCCAGAGCT-
CAAACCAGAGAGCAA-3′ (forward) and 5′-GTACCTCGAGTCCATG-
GATGTGCAAAGACTGTCCAGCTGT-3′ (reverse) to PCR amplify a 450-
bp Chl fragment containing novel NcoI and XhoI sites and then
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fragment in the Chl pCS2+ vector (described above). GFP sequences
were then inserted into theChl CS2+vector between thenovelNcoI andFig. 1. Alignment of Chl and murine CHL deduced amino acid sequences. (A) Alignment of th
the site at which CHL1 is cleaved by BMP1/Tolloid-like proteinases. (B) Schematic of shar
(parentheses) between CRs of Chl and murine (m), human (h), and chick (c) CHL1 and CHL2
(Nakayama et al., 2001; Sakuta et al., 2001) and form of CHL2 of similar length (NakayamaXhoI sites. TheChl–GFPpCS2+constructwas linearizedwithBssHII, and
capped mRNA was transcribed using the mMessage mMachine SP6 kit
(Ambion).e Chl amino acid sequence with those of murine (m) CHL1 and CHL2. An arrow denotes
ed CHL protein domain structure and comparison of percents identity and similarity
. Alignment was with CLUSTAL W. Sequences of the longer/ventroptin-α form of CHL1
et al., 2004), both of which are similar in length to Chl, were used for the alignment.
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Identiﬁcation and cloning of zebraﬁsh chordin-like (Chl)
BLAST searches of zebraﬁsh genome databases with mouse CHL2
amino acid sequences found only a single CHL sequence, which like
CHL1 and CHL2 possesses three cysteine-rich domains (CRs) (Fig. 1).
Searches with mouse CHL1 amino acid sequences or mammalian
CHL1 or CHL2 DNA sequences did not identify additional zebraﬁsh
CHL sequences. Alignment of the zebraﬁsh Chl sequence with those of
mouse CHL1 and CHL2 (Fig. 1A) revealed pronounced homology
between the CRs of the three proteins, with highest levels of
homology found between the CR3 domains of the three proteins
(Fig. 1B). Homology between non-CR portions of the three proteins
was markedly lower. Alignment of the Chl CRs with those of CHL
proteins identiﬁed in various other species, showed a fair degree of
conservation, with homologies ranging between 46% and 66% identity
(Fig. 1B). Overall, Chl was found to be 37% identical/55 % similar to
mouse CHL1 and 44% identical/61% similar to mouse CHL2.
Chl exhibits a temporal expression proﬁle distinct from but overlapping
that of Chd
To determine the temporal pattern of Chl developmental expres-
sion and compare it to that of Chd, RT-PCR was performed on the RNA
from a series of developmental stages, from the 8-cell stage to 48 h
post fertilization (hpf). As can be seen (Fig. 2A), temporal expression
patterns for Chl and zChd differ but overlap. An unexpected ﬁnding
was the relatively high levels of Chl RNA at the 8- and 64-cell stages
(1.25 and 2 hpf, respectively), suggesting Chl to be a maternally
transmitted factor, as it appears before the midblastula transition
(MBT, 2.75 hpf), at which point transcription of most zygotically
expressed genes commences (Kane and Kimmel, 1993; Mathavan
et al., 2005). Results also showed Chl RNA to be somewhat reduced by
the dome stage and 30% epiboly (4.33 and 4.67 hpf, respectively) and
at very much reduced levels by the shield stage (6 hpf), suggesting a
fairly rapid turnover of maternal Chl transcripts. A lower level of Chl
expression was also detectable from 30% epiboly through the tailbud
stage (10 hpf), during the process of gastrulation, which occurs from
50% epiboly through the tailbud stage (Kimmel et al., 1995).
Expression levels of Chl are at lowest levels at 24 hpf, but levels
increase at 48 hpf, consistent with roles for Chl in later development.
RT-PCR was performed for an increased number of cycles (40 cycles)
to clearly demonstrate the presence of Chl RNA transcripts from shieldFig. 2. Comparison of the temporal distributions of Chl and Chd expression during
embryogenesis. (A) RT-PCR analysis of Chl and Chd RNA levels was performed for
harvested embryos from 8-cell to 48-hpf stages. PCRwas for 35 cycles. Expression levels
of transcription factor 3 (tcf3) RNA are shown as a loading control. (B) RT-PCR was
performed using 40 cycles to demonstrate presence of Chl RNA transcripts from shield
stage through 24 hpf.stage through 24 hpf (Fig. 2B). Chd RNA transcripts are readily
detectable at the 1000-cell stage, followed by maximum expression
levels at the sphere stage, prior to the onset of gastrulation, and
persisting through the tailbud stage, after which there is a somewhat
of a decline in expression levels. These data support the possibility of
both distinct and overlapping developmental roles for Chl and Chd.Spatial expression of chl compared to chd
To explore the spatial distribution of Chl during embryogenesis,
whole-mount in situ hybridization was performed (Fig. 3) with a
probe directed against the ﬁrst ﬁve exons of the chl gene. Ubiquitous
expression of Chl was observed at high levels throughout early
embryogenesis (8-cell-dome stages), with expression levels tapering
off at 30% epiboly, and at markedly reduced levels at the shield stage
and midgastrulation (70% epiboly). In contrast, and consistent with
RT-PCR results, strong Chd expression was readily detectable from
sphere stage through 70% epiboly and, as expected (Miller-Bertoglio
et al., 1997), was highly expressed throughout gastrulation on the
dorsal aspect of the embryo (Figs. 3M–Q), in agreement with its role in
dorsoventral patterning. Interestingly, at 24 hpf, Chl and Chd showed
similar expression patterns, with strongest signal for both localized to
mid and hindbrain and tailbud (Figs. 3S and T). At 48 hpf, Chl and Chd
signals are still seen to co-localize in brain (Figs. 3U and V).Chl is a substrate of BMP1/Tolloid-like proteinases
An important aspect of CHD function is its proteolytic cleavage by
BMP1/Tolloid-like proteinases, for the activation of bound ligands
(Hopkins et al., 2007). To determine whether Chl function might also
be regulated by these proteinases, recombinant Chl was prepared and
assayed for cleavage by zebraﬁsh Bmp1a (Jasuja et al., 2006; Muraoka
et al., 2006). As can be seen, the size of secreted recombinant Chl,
puriﬁed from conditioned medium, is ∼55-kDa (Fig. 4A). Upon
incubation of the recombinant Chl with Bmp1a in an in vitro cleavage
assay (Fig. 4B), immunoblotting with antibody against the C-terminal
FLAG epitope detected a single ∼30-kDa cleavage fragment. Thus, Chl
is indeed a substrate for BMP1/Tolloid-like proteinases, and the size of
the cleavage product is consistent with a cleavage event that
occurs between CRs 2 and 3. Cleavage sites for BMP1/Tolloid-like
proteinases overwhelmingly have aspartate residues in the P1′ posi-
tion, just N-terminal to the scissile bond (Hopkins et al., 2007). There
are four aspartates between Chl CRs 2 and 3, all clustered within the
ﬁrst 28 amino acid residues just C-terminal to CR2 (Fig. 1), and it is
probable that BMP1/Tolloid-like proteinases cleave at one or more of
these sites.
To determine whether mammalian CHL1 and CHL2 might be
substrates for cleavage by BMP1/Tolloid-like proteinases, recombinant
murine CHL1 and CHL2were prepared and assayed for cleavage by each
of the four different mammalian BMP1/Tolloid-like proteinases: BMP1,
mammalian Tolloid (mTLD), mammalian Tolloid-like 1 (mTLL1), and
mammalian Tolloid-like 2 (mTLL2) (Scott et al., 1999). The short formof
CHL1 was used for these studies, as it was found to be markedly more
stable, in the absence of added proteinase, than was the long form. As
can be seen, three of the four mammalian proteinases readily cleaved
CHL1 (Fig. 4C), but none of the four proteinaseswere observed to cleave
CHL2 (Fig. 4D). Enough of the ∼20-kDa CHL1 cleavage product was
obtained to allowNH2-terminal amino acid sequencing, which gave the
sequence DGDIFRQP. This shows cleavage to have occurred at Asp185,
just C-terminal to CR2 (Fig. 1), one of several sequences noted by
Nakayama et al. (2001) as potential cleavage sites for BMP1/Tolloid-like
proteinases. Thus, althoughChl showsmore sequence similarity toCHL2
than to CHL1, it is more similar to at least the short form of CHL1 in its
ability to serve as a substrate for BMP1/Tolloid-like proteinases.
Fig. 3. Comparison of the spatial distributions of Chl and Chd expression during embryogenesis. Whole-mount in situ hybridization compares the spatial distribution patterns of Chl
(B–I) and Chd expression (J–Q) in 8-cell stage through 70% epiboly embryos. (A) Eight-cell embryo hybridized with a sense Chl control probe. Anti-sense probes were hybridized to
(B and J) 8-cell, (C and K) 64-cell, (D and L) 1000-cell, (E and M) sphere stage, (F and N) dome stage, (G and O) 30% epiboly, (H and P) shield stage, and (I and Q) 70% epiboly
embryos. (R) The 24-hpf embryo hybridized with a sense Chl control probe. Signal resulting for hybridization to anti-sense probes for Chl (S and U) and Chd (T and V) is shown for
24 hpf (S and T) and the head regions of 48 hpf (U and V) embryos. Arrowheads mark overlapping Chl and Chd signals in 24-hpf tailbud. Asterisks mark midbrain and hindbrain
structures enriched for both Chl (S) and Chd (T) signal at 24 hpf. Similar overlapping signals for Chl (U) and Chd (V) are evident in the brains of 48-hpf embryos.
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Fig. 4. Chl and CHL1 are substrates for BMP1/Tolloid-like proteinases. (A) A Coomassie-
stained SDS–PAGE gel is shown of protein molecular weight markers (lane 1) and of
∼55-kDa secreted and puriﬁed Chl (lane 2). (B–D) Immunoblotting with anti-FLAG
antibody (B and D) or anti-CHL1 antibody (C) is shown for in vitro assays in which
recombinant Chl was incubated in the absence (−) or presence (+) of Bmp1a (B) or in
which recombinant short, neuralin form of CHL1 (C) or CHL2 (D) was incubated in the
absence (o/n) or presence of mammalian BMP1, mTLD, mTLL1, or mTLL2. Positions of
the ∼30-kDa Chl (B) and ∼20-kDa and smaller CHL1 (C) cleavage products are shown.
In B and D, asterisks mark the positions of FLAG-tagged BMP1 and related proteinases.
Molecular masses (in kDa) are indicated for protein standards.
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is counteracted by Bmp1a
To gain further insights into Chl function, 500 pg Chl RNA was
injected into one- to two-cell stage embryos for overexpression
analysis, and phenotypes were analyzed 24 h later (Fig. 5). Embryos
injected with Chl revealed a variety of dorsalized phenotypes, with
most embryos showing mild class 1 to class 2 dorsalization (Fig. 5B),
including partial to full loss of tail ﬁn (Mullins et al., 1996); and a
fraction showing moderate to severe (class 3 to class 5) dorsalization
(Fig. 5C), characterized by complete tail loss to complete loss of
ventral features and an upward twisting of the trunk. These data are
consistent with the possibility that Chl, like CHL1 and CHL2
(Nakayama et al., 2001, 2004; Sakuta et al., 2001), is capable of
binding and inhibiting the activity of TGFβ-like BMPs involved in
ventralization during gastrulation.
As Bmp1a is capable of in vitro cleavage of Chl (Fig. 4A), we sought
to determine whether such cleavage might occur in vivo, thereby
affecting Chl function. Towards this end, Chl was overexpressed in
zebraﬁsh embryos in the presence or absence of overexpressed
Bmp1a. Injections of embryos with 500-pg Bmp1a RNA alone resulted
in embryo ventralization, characterized by reduced head structures,
thickening of the tail, and blood pooling at 24 hpf (Fig. 5D), consistent
with the role of Bmp1a in dorsoventral patterning and similar to
previous data (Jasuja et al., 2006). Overexpression of Chl and Bmp1a
together resulted in a majority of ventralized embryos, similar to
those seen with Bmp1a alone (Figs. 5D and E), consistent with the
possibility that in vivo cleavage by Bmp1a antagonizes the ability ofChl to dorsalize. Consistent with the above ﬁndings, whole-mount in
situ hybridization for the dorsal marker Chd showed embryos in
which Chl was overexpressed to display expansion of the Chd
expression domain (Figs. 5H and L), embryos in which Bmp1a alone
was overexpressed to display reduction in the Chd expression domain
(Figs. 5I and M), and embryos in which Bmp1a and Chl were co-
overexpressed (Figs. 5J and N) to display reduction in the Chd
expression domain, compared to embryos in which Chl alone was
overexpressed (Figs. 5H and L). Numbers of embryos and quantiﬁca-
tion of reductions and expansions of Chd domains for the experiments
of Figs. 5G–N are displayed in Supplemental Table 1.
Chl knockdown
To determine the in vivo roles of Chl, loss-of-function experiments
were performed in which endogenous Chl expression was knocked
down, via independent use of two anti-senseMOs, designated 5′1-MO
and TrSt-MO (Fig. 6A), designed to target 5′-UTR and translation start
site sequences, respectively. To assess ability of these MOs for speciﬁc
and efﬁcient knockdown of Chl sequences, a construct was developed
with GFP sequences fused 3′ of Chl 5′-UTR and coding sequences, for
expression of RNA encoding a recombinant protein in which GFP is
fused to the Chl C-terminus (Chl–GFP). Embryos were then injected at
the one-cell stage with 1 ng Chl–GFP RNA, plus 0.5 mM of 5′1-MO, or
standard control (StCon) MO. Analysis at 70% epiboly showed that,
whereas embryos injected with StCon-MO plus Chl–GFP RNA
displayed easily detectable GFP signal (Fig. 6C), GFP signal was
efﬁciently knocked down in embryos injected with 5′1-MO plus Chl–
GFP RNA (Fig. 6E). Similar results were obtained using the TrSt-MO
(data not shown). Such experiments helped demonstrate the ability of
the described MOs to recognize and effectively knock down Chl
expression.
To examine the in vivo function of Chl, MOs were injected at a
concentration of 0.5 mM (to a ﬁnal concentration of 0.5 μM in the
embryo) into one- to two-cell stage embryos for knockdown of
endogenous Chl. Injection of 0.5 mM 5′1-MO (0.5 mM) resulted in
arrest at about the shield stage and lysis of ∼35% of embryos
(n=138), with remaining embryos surviving past 24 hpf. The latter
embryos died at about 72 hpf and displayed a variety of defects that
persisted from 24 to 72 hpf and included reduced size in features such
as head (microcephaly) and eyes, truncated tail (shortened body
axis), and enlarged yolk sac (Fig. 6G). Similar results were obtained
using TrSt-MO (data not shown). To address the possibility that non-
speciﬁc, off-target effects of the Chl-MOs might contribute to this
phenotype, 0.5 mM 5′1-MO was co-injected with 0.25 mM of a p53
MO previously shown to suppress off-target effects (Robu et al.,
2007). About 25% of the embryos of this group (n=146) underwent
lysis, with the remainder surviving until ∼72 hpf, and displaying a
phenotype (Fig. 7H) identical to that seen in embryos injected with
0.5 mM 5′1-MO alone (Fig. 7G). Thus, evidence suggests the
phenotype observed in 24- to 72-hpf embryos treated with 5′1-MO
and TrSt-MO to be speciﬁc to Chl knockdown.
In contrast to results obtained with the above MOs, which would be
expected to inhibit translation of both zygotic and maternal Chl mRNA,
injection of embryos with 0.5 mM of an MO designed to interfere with
correct RNA splicing (SP-MO), which would be expected to target
zygotic but not maternal Chl transcripts (Draper et al., 2001), produced
the relativelymildphenotypeof curvingof the tail, and sometimesof the
body axis, at 48 hpf (Fig. 6I). Importantly, injection of embryos with
lower concentrations of 5′1-MO or TrSt-MO (e.g. 0.25 mM) resulted in
the same phenotype at 48 hpf (data not shown) as that achieved with
1 mM SP-MO, thus offering additional evidence that phenotypes
achievedwith the variousMOs used in this study are speciﬁcally caused
by knockdown of Chl expression. An RT-PCR control was used to
demonstrate the efﬁcacy of SP-MO for interfering in the splicing of Chl
RNA, starting at 70% epiboly (Fig. 6J). Asmaternal RNA is already spliced,
Fig. 5. Effects on dorsoventral patterning by overexpression of Chl in the presence or absence of Bmp1a. Phenotypes are shown of an uninjected 24-hpf control embryo (A), 24-hpf
embryos with mild dorsalization (B) or moderate dorsalization (C) after injection with 600 pg Chl RNA, and 24-hpf embryos injected with 500 pg Bmp1a RNA (D), or a combination
of 600 pg Chl and 500 pg Bmp1a RNA (E). An arrowhead marks partial tail ﬁn loss and asterisks mark blood pooling, signs of mild dorsalization or ventralization, respectively.
(F) Quantiﬁcation of phenotypes at 24 hpf. Severity of dorsalization (DO) is numerically classiﬁed as per Mullins et al. (1996). Degree of ventralization (VE) was not numerically
classiﬁed. Whole-mount in situ hybridization is shown (animal view, panels G–J; lateral view, panels K–N) for expression of the dorsal marker Chd at 70% epiboly for uninjected
embryos (G and K) or embryos injected, as above, with RNA for Chl alone (H and L), Bmp1a alone (I andM), or both Chl and Bmp1a (J and N). Arrowheads mark extent of epiboly. All
embryos in panels G–N are from the same clutch of eggs and same developmental stage.
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readily detectable by shield stage and may be the predominant form of
Chl RNA transcripts at 70% epiboly and at 24 hpf. Faint bands
corresponding to unspliced and/or misspliced RNA, and thus zygotic
transcription, may also be discernable at 30% epiboly but were near the
limits of detection (Fig. 6J).
Synergistic effects of Chl- and Chd-MOs demonstrate overlapping,
redundant roles for these two gene products in dorsoventral patterning of
the zebraﬁsh embryo
Because RT-PCR and in situ hybridization results clearly showed
coexpression of Chd and Chl from the 1000-cell stage onwards (Figs. 2and 3) and because Chl overexpression dorsalizes embryos (Fig. 5),
we tested the effect of simultaneously injecting Chl- and Chd-MOs to
determine whether these two genes might demonstrate functional
overlap in formation of the dorsoventral axis. Injection of 0.1 mM Chl
5′1-MO (Fig. 7B) or of 0.5 mM Chl SP-MO (Fig. 7C) produced mild
morphant phenotypes at 24 hpf, while injection of 0.026 mM Chd-MO
(Fig. 7D) produced a mild ventralized phenotype at 24 hpf. However,
when 0.026 mM Chd was co-injected with either 0.1 mM 5′1-MO
(Fig. 7E) or 0.5 mM SP-MO (Fig. 7F), severely ventralized phenotypes
were obtained, in which reduced head structures, gross thickening of
the tail, and blood pooling were observed at 24 hpf. Consistent with
morphological results in Figs. 7A-F, in situ hybridization demonstrated
synergistic effects from co-injection of Chl 5′1-MO and the Chd-MO in
Fig. 6. Treatment with Chl-speciﬁc anti-sense MOs. (A) A schematic is shown representing MOs targeting the Chl translation start site (TrSt-MO), or a non-overlapping region of the
chl 5′UTR (5′1-MO), or the acceptor splice site of chl exon 4 (E4). Brightﬁeld (B and D) and darkﬁeld (C and E) exposures are shown of 70% epiboly embryos injected at the one-cell
stage with 1 ng Chl–GFP RNA and 0.5 mM of either standard control (StCon) MO (B and C) or 5′1-MO (D and E). A comparison at 48 hpf is shown of embryos treated with 0.5 mM
standard control (StCon) MO (F), 0.5 mM 5′1-MO (G), 0.5 mM 5′1-MO plus 0.25 mMp53-MO (H), 0.1 mM 5′1-MO (I), or 0.5 mM SP-MO (K). (L) RT-PCR demonstrates the efﬁcacy of
SP-MO in inhibiting chl RNA splicing. Inhibition of splicing leading to accumulation of unspliced RNA, represented by one to two lower mobility bands, is clearly seen for shield stage,
70% epiboly, and 24-hpf embryos. Faint bands corresponding to unspliced RNAmay also be discerned at 30% epiboly, especially upon comparison of lanes for samples from untreated
(WT 30%) and splice site MO-treated (SP-MO 30%) embryos. Expression levels of transcription factor 3 (tcf3) RNA are shown as a loading control.
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expansion of the expression domain of the ventral marker GATA2
(Fig. 7G, with quantiﬁcation of data in Supplemental Table 1). The fact
that co-injecting 5′1-MO and the Chd-MO results in signiﬁcantlymore
severe effects than either MO injected alone supports the conclusion
of overlapping, redundant Chl and Chd function in dorsoventral
patterning.
As 5′1-MO targets 5′-UTR sequences, it would be expected to
knock down expression of Chl from both maternally and zygotically
transcribed RNA. In contrast, SP-MO, a splice site MO, would beexpected to target zygotically, but not maternally transcribed Chl
RNA, as the latter is already spliced. Thus, it is of interest that SP-MO,
as well as 5′1-MO, is able to synergize with subthreshold amounts of
Chd to produce severely ventralized phenotypes. These results are
consistent with the interpretation that a portion of Chl dorsoventral
patterning function, redundant with that of Chd, derives from
zygotically transcribed RNA.
To address the possibility that non-speciﬁc, off-target effects of one
or both MOs might contribute to the synergistic ventralizing effects
caused by co-injection of Chl- and Chd-MOs, 5′1-MO and the Chd-MO
Fig. 7. Effects in embryos co-injected with MOs against both Chl and Chd demonstrate overlapping roles for these genes in dorsoventral patterning. A comparison is shown at 24 hpf
of embryos treated with 0.5013 mM StCon-MO (A), 0.1 mM Chl 5′1-MO plus 0.0013 mM StCon-MO (B), 0.5 mM Chl SP-MO plus 0.0013 mM StCon-MO (C), or 0.026 mM Chd-MO
alone (D) or with combinations of 0.1 mM Chl 5′1-MO plus 0.026 mM Chd-MO (E) or 0.5 mM Chl SP-MO plus 0.026 mM Chd-MO (F). Single injections of 5′1-MO (B) and SP-MO
(C) had added StCon-MO tomatch total amounts of MOs used in the co-injection experiments (E and F). (G) In situ hybridization shows altered expression patterns at 30% epiboly for
the dorsal marker Chd (top panel) and at 70% epiboly for the ventral marker Gata2 (bottom panel) in response to treatment of embryos with the Chd-MO (CHD-MO) and Chl 5′1′MO
(Chl-MO), in comparison to embryos treated with StCon-MO (Cont-MO). Concentrations of MOs used were the same as those used in panel A. Note the increased reduction of the
Chd expression domain and enlargement of the Gata2 expression domain in response to co-injection with the Chd and Chl-MOs.
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MO and the Chd-MOwith the p53MOhad no effect on ventralization of
embryos (Fig. 8), thus offering evidence that the ventralized phenotype
achieved by co-injection of Chl- and Chd-MOs is speciﬁc.
Chl, murine CHL1 and CHL2, and Chd can rescue embryos ventralized by
co-injection of Chl- and Chd-MOs
Consistent with the probability that Chl and murine CHL1 and CHL2
are all capable of antagonizing BMP signaling, overexpression of each
resulted in dorsalization of zebraﬁsh embryos (Fig. 9A). As a further testof the overlapping functions of Chl and Chd in dorsoventral patterning
and as a test for the speciﬁcity of knockdown with Chl-MOs, we
investigated whether embryos ventralized by co-injection of Chl- and
Chd-MOs could be rescued by overexpression of Chl. As can be seen in
Fig. 9B and Table 1, whereas the vast majority (98%) of embryos co-
injectedwith Chl- and Chd-MOs aremoderately to severely ventralized,
co-overexpression of Chl in the same embryos achieves rescue to the
extent that 11% of embryos have dorsalized phenotypes, and another
39% are onlymildly ventralized. Interestingly, overexpression ofmurine
CHL1 or CHL2 also rescued embryos (Fig. 9 and Table 1), implying some
conservation of function between Chl and the two CHLs of higher
Fig. 8. Synergistic effects of Chl- and Chd-MOs in inducing ventralization does not involve p53-mediated off-target effects. (A) A comparison is shown of 24-hpf embryos treated with
0.38 mM StCon-MO, 0.1 mM Chl 5′1-MO, 0.026 mM Chd-MO plus 0.25 mM p53-MO, 0.1 mM Chl 5′1-MO plus 0.026 mM Chd-MO, or with 0.1 mM Chl 5′1 plus 0.026 mM Chd-MO
and 0.25 mMp53-MO. (B) Quantiﬁcation of phenotypes at 24 hpf. Severity of dorsalization (D) is numerically classiﬁed as perMullins et al. (1996). Degree of ventralization (VE) was
not numerically classiﬁed. (C–D) Whole-mount in situ hybridization is shown for expression of the dorsal marker Chl at 30% epiboly for embryos treated with 0.38 mM StCon-MO
(C), 0.1 mM Chl 5′1-MO plus 0.25 mM p53-MO (D), 0.026 mM Chd-MO plus 0.25 mM p53-MO (E), or 0.1 mM Chl 5′1 plus 0.026 mM Chd-MO and 0.25 mM p53-MO.
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expressed in the experiments of Fig. 9 and Table 1 rescued more
effectively than did Chl, this CHL1was fused to an Fc domain to enhance
stabilization of the protein, as overexpression of murine CHL1 not fused
to an Fc domain was relatively ineffective at rescue (not shown). Thus,
the relatively efﬁcient rescue by CHL1-Fcwas probably enhanced by the
increased stability of the protein due to the added Fc domain. We
speculate that the relatively strong ability of murine CHL2 to rescue
embryos may be due to its imperviousness to cleavage by endogenous
BMP1-like proteinases, as we have shown CHL2 to not be cleaved bysuch enzymes (Fig. 4). Chd RNA was also able to rescue the
ventralization phenotype resulting from co-injection of Chl- and Chd-
MOs (Supplemental Fig. 1), adding additional evidence that the
ventralized phenotype is in all respects speciﬁc and not due to off-
target effects.
Discussion
CHD/SOG is the prototype of a group of CR-containing proteins,
members of which bind and modulate signaling by extracellular
Fig. 9. Chl and murine CHL1 and CHL2 can rescue embryos ventralized by co-injection of Chl- and Chd-MOs. (A) Embryos were dorsalized by injection of RNA encoding Chl, murine
CHL1 fused to an Fc domain (mCHL1-Fc), or CHL2 (mCHL2) (1 ng, 80 pg, or 1 pg, respectively). Also shown, for comparison, is a representative embryo injected with 0.1 mM of
StCon-MO. (B) Embryos co-injected with Chd-MO and Chl 5′1-MO are for the most part moderately to severely ventralized, whereas overexpression of Chl RNA rescues embryos co-
injected with Chd-MO and Chl 5′1-MO, such that many are only mildly ventralized (shown) or weakly or strongly dorsalized (not shown). Overexpression of murine CHL1-Fc
(mCHL1-Fc) or murine CHL2 (mCHL2) also rescued embryos co-injected with Chd-MO and Chl 5′1-MO, resulting in a range of phenotypes that included mildly ventralized (left) and
severely dorsalized (right).
Table 1
Chl, Chd, and murine CHL1 and CHL2, can rescue embryos ventralized by co-injection of Chl- and Chd-MOs.
Sample injected n Normal/bent tail Strong dorsalized










StCon-MO 96 100% 0% 0% 0% 0% 0% 0%
5′1-MO (0.1 mM) 69 100% 0% 0% 0% 0% 0% 0%
Chd-MO (0.026 mM) 88 0% 0% 0% 98% 2% 0% 0%
SP-MO (0.5 mM) 43 100% 0% 0% 0% 0% 0% 0%
5′1-MO+Chd-MO (0.1 mM/0.026mM) 196 0% 0% 0% 2% 31% 67% 0%
SP-MO+Chd-MO (0.5 mM/0.026 mM) 56 0% 0% 0% 11% 21% 68% 0%
Chl RNA (1 ng) 68 0% 7% 93% 0% 0% 0% 0%
mCHL2 RNA (1 pg) 41 0% 19% 49% 0% 0% 0% 32%
mCHL1-Fc RNA (80 pg) 28 11% 28% 50% 0% 0% 0% 11%
5′1-MO+Chd-MO+Chl RNA 89 0% 6% 5% 39% 30% 16% 4%
5′1-MO+Chd-MO+mCHL2 RNA 52 0% 14% 42% 17% 4% 0% 23%
5′1-MO+Chd-MO+mCHL1-Fc RNA 26 0% 12% 27% 27% 19% 4% 11%
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proteins is critical to formation of the dorsoventral axis in a broad
range of species, as well as in wing vein patterning in Drosophila, and
neural induction in vertebrates (De Robertis and Kuroda, 2004; Garcia
Abreu et al., 2002). However, although experiments involving in vitro
binding, overexpression in Xenopus embryos, and misexpression in
chick retina have previously shown that vertebrate CR-bearing
proteins CHL1 and CHL2 can bind BMP 2 and 4, and other TGFβ-like
ligands (Nakayama et al., 2001, 2004; Sakuta et al., 2001), in vivo
functions of CHL proteins, particularly in early development, are
largely unknown due to lack of loss-of-function data.
The D. rerio CR-protein Chl described here has slightly more
homology to mammalian CHL2 than to mammalian CHL1. Moreover,
comparison of zebraﬁsh and murine genomic contigs found both the
genes for Chl andmurine CHL2 to be ﬂanked by the genes for sialidase 3
and polymerase δ3, showing corresponding segments of D. rerio
chromosome 21 and Mus musculus chromosome 7 to have shared
synteny. However, although the gene for zCHL thus appears to
correspond to the mammalian gene for CHL2, a separate zebraﬁsh
gene corresponding tomammalian CHL1 has not been identiﬁed, despite
multiple Blast searches of the zebraﬁsh genome databases with murine
andhumanCHL1andCHL2aminoacid andnucleotide sequences. Thus, it
is not yet clearwhether separate genes corresponding to CHL1 and CHL2
exist in zebraﬁsh, or whether, instead, Chl may serve roles in zebraﬁsh
distributed between CHL1 and CHL2 in other vertebrate species. In
support of the latter possibility, it is of interest that Chl, despite greater
sequence homology to CHL2, resembles CHL1 rather than CHL2 in ability
to be cleaved and thus regulated by BMP1/Tolloid-like proteinases.
Herewe show temporal and spatial patterns of expression of Chl to
differ from, but overlap those of Chd, suggestive of differences, but
supporting the possibility of overlap, in developmental roles of these
two proteins. Analysis of the temporal pattern of Chl expression,
spanning the 8-cell stage to 48 hpf, found highest Chl RNA levels at the
8-cell stage, thus suggesting Chl to be maternally transmitted, as
initiation of zygotic expression does not occur for most genes until the
MBT at the 512- to 1000-cell stage (2.75 hpf) (Kane and Kimmel,
1993; Mathavan et al., 2005). Thus, some portion of Chl function is
likely provided by maternally supplied Chl, although zygotically
transcribed Chl RNA is also produced and has a demonstrated role in
dorsoventral patterning, as described in the current study. Although
previous studies (Kosinski et al., 2007; Nakayama et al., 2001, 2004;
Oren et al., 2004; Sakuta et al., 2001; Wu and Moses, 2003) have
provided no indication that CHL1 or CHL2 gene products might be
maternally provided, this may simply be because previous studies
have not analyzed CHL1 or CHL2 expression as early in vertebrate
development as was done here for Chl.
In normal vertebrate development, CHD, prototype of CR-containing
proteins, is thought to dorsalize gastrula stage embryos by binding
TGFβ-like BMPs, thus inhibiting their interactions with cognate cell
surface receptors (Piccolo et al., 1996; Schulte-Merker et al., 1997).
However, loss of CHD function in various model systems has shown
surprisingly minor consequences to dorsoventral patterning (Bachiller
et al., 2000; Hammerschmidt et al., 1996; Khokha et al., 2005). In
zebraﬁsh, for example, substantially more dorsal and dorsolateral
structures persist even in strong Chd mutants (Hammerschmidt et al.,
1996) than in embryos completely ventralized by overexpression of
BMPs (Schmid et al., 2000). This has suggested that other gene products
might functionally overlap with Chd in dorsalization of the early
embryo. It has previously been shown that the extracellular BMP
antagonists noggin and follistatin are together capable of providing
some functional overlap with CHD in Xenopus (Khokha et al., 2005),
although the morphant phenotypes in these triple knockdown experi-
ments suggested the existence of additional BMP antagonists, needed to
prevent formation of the most ventral fates (Khokha et al., 2005). In
zebraﬁsh, noggin1 (Nog1) and follistatin-like2 (Fstl2) appear to
functionally overlap with Chd (Dal-Pra et al., 2006).As a CR-containing protein and in view of the fact that both CHL1
and CHL2 have been shown to be capable of interacting with various
TGFβ-like ligands (Nakayama et al., 2001, 2004; Sakuta et al., 2001), it
seems likely that Chl would exert its developmental effects, at least in
part, by modulating the activity of such ligands. In fact, it has been
proposed that in chick, CHL1 may be involved in modulating
dorsoventral and anteroposterior patterning in the developing retina,
via effects on signaling by BMP4 and related ligands (Sakuta et al.,
2001). Here we demonstrate, via gain-of-function experiments, that
Chl overexpression dorsalizes embryos, consistent with ability to bind
and inhibit TGFβ-like BMPs. More importantly, loss-of-function
experiments, employing co-injection of Chl- and Chd-MOs, show
these two genes to have overlapping and cooperative functions crucial
to correct dorsalization of the zebraﬁsh embryo. Remarkably, the
extent of ventralization achieved in embryos in which both Chl and
Chd are simultaneously knocked down appears to exceed that
previously achieved via triple knock down of Chd, Nog1, and Fstl2
(Dal-Pra et al., 2006), implying an important role for Chl in normal
patterning of the embryonic dorsoventral axis, presumably, along
with Chd, via antagonizing signaling by Bmp2–Bmp7 heterodimers,
which have been shown to be responsible for eliciting the signaling
response required for dorsoventral patterning in zebraﬁsh (Little and
Mullins, 2009).
Interestingly, simultaneous knock down of Chd and Chl via
treatment with a Chd-MO in conjunction with either a 5′-UTR Chl-
MO, expected to inhibit both zygotic andmaternal Chl, or with a splice
site Chl-MO, expected to inhibit only zygotic Chl, both produced
severe ventralization of embryos. These results suggest that an at least
some component of Chl dorsalizing function, redundant with that of
Chd, derives from zygotic Chl expression, which appears to commence
at least as early as the shield stage (Fig. 6J). However, we note that in
these experiments the dose of MO that could be used was lower for
the 5′UTR Chl-MO than for the splice site Chl-MO (see below), and our
results do not preclude potentially important roles for maternal Chl in
either the initiation or maintenance of dorsoventral patterning.
Diffusion of CHD from a dorsal organizer is thought to establish a
gradient of antagonism to BMP signaling that, in large part,
establishes patterning of the dorsoventral axis in vertebrates (Piccolo
et al., 1996). Consistent with this model, in situ hybridizations in the
present study showed Chd expression to be localized to the dorsal
aspect of the embryo just prior to gastrulation, at the dome stage and
30% epiboly, and during gastrulation, at the shield stage and 70%
epiboly (Fig. 3). In contrast, in situ hybridization did not detect
dorsoventral asymmetry in Chl RNA distribution prior to gastrula-
tion, as such RNA appeared to be ubiquitous in embryos from the 8-
cell stage through 30% epiboly. However, Chl at these stages is likely
predominantly maternal since, as noted above, zygotic Chl RNA
thought essential to dorsoventral patterning is not expressed at
readily detectable levels until during gastrulation, at the shield stage.
It is not yet clear what role maternal Chl may contribute to
dorsoventral patterning.
At the shield stage and 70% epiboly, in situ hybridization signal for
Chl was near the limits of detection. Thus, it is not yet certain whether
or not dorsoventral asymmetry exists for zygotic Chl expression at
these stages. However, even if there is an absence of dorsoventral
asymmetry in Chl expression during gastrulation, Chl could still
contribute to establishing a dorsoventral gradient of antagonism to
BMP signaling, if functional Chl protein was asymmetrically distrib-
uted in the embryos. Such asymmetry could occur either via
asymmetric dorsoventral binding of Chl protein to extracellular
components or via Chl cleavage by BMP1-like proteinases. In regard
to the latter possibility, we show here that Chl is cleaved by such
proteinases, and we have previously shown at least one of these
proteinases to be preferentially expressed in ventral portions of the
zebraﬁsh embryo during gastrulation (Jasuja et al., 2006). Even in the
absence of a dorsoventral gradient of Chl expression or protein, there
457A.M. Branam et al. / Developmental Biology 341 (2010) 444–458is the possibility that Chl may aid in patterning the dorsoventral axis
in a permissive way, by lowering baseline levels of BMP signaling
throughout the embryo, thus aiding Chd in achieving amore complete
inhibition of BMP signaling in dorsal regions.
In regard to possible roles for maternal Chl, RNA of which declines
rapidly prior to gastrulation onset, we have found that higher
concentrations (e.g. 1 mM) of the 5′-UTR MO used in the present
study, or similarly high concentrations of two other non-overlapping
MOs targeting either 5-UTR or translation start site sequences, results in
developmental arrest in the blastula stage. This developmental arrest is
due to a block in cell cycle progression, an effect not obtained using the
SP-MO splice site MO speciﬁc for zygotic Chl (data not shown). It is not
presently clearwhether this effect is speciﬁc to knock down ofmaternal
Chl, as efforts to rescue this particular phenotype via overexpression of
Chl RNAwere unsuccessful (our unpublished data). Nevertheless, given
its initially high levels of expression in the pregastrula embryo, it seems
likely that maternal Chl plays a role in these early stages. It is possible
that this putative early role is functionally distinct from a latter role for
Chl in dorsoventral patterning. Alternatively, maternal Chl may
contribute, together with zygotic Chl, to the overall function of this
gene in the regulation of dorsoventral patterning. The latter is a
possibility thatwe cannot rule out, as sucha rolemaybe obscured by the
cell cycle progression defect induced by high concentrations of 5′UTR or
translation start site Chl-MOs.
In summary, we describe the zebraﬁsh CR-protein Chl and
demonstrate it to be an important BMP antagonist with functions that
overlap and synergize thoseof Chd in formationof the dorsoventral axis.
Zygotically transcribed Chl, expression of which commences at least as
early as the shield stage, seems important to this role in dorsoventral
patterning of the axis, and this role in patterning, as for that of Chd, is
likely affected via cleavage by BMP1-like proteinases. The roles of
relatively high levels of maternally provided Chl remain to be deﬁned.
Beyond further exploring the roles of Chl in zebraﬁsh development, it
will be of great interest to determine whether CHL1 and/or CHL2 play
similar roles in higher vertebrates.
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